Lifetime Impact of Achondroplasia Study in Europe-LIAISE
Sponsored by BioMarin Pharmaceutical
About this trial
Last updated 4 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 5 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
1. Individuals with a documented diagnosis of achondroplasia based on:
2. ≥ five years of age at the time of enrolment
3. Has the cognitive and linguistic capacities necessary to complete questionnaires in the language of his/her country (and/or parents/legally acceptable representatives, as applicable)
4. Agrees to participate in the study and has read, understood, completed and signed:
5. Has medical records available for at least the five years prior to the date of enrolment.
Exclusion Criteria
1. Currently participating, or participated within the last six months, in
2. Currently participating or participated in any BioMarin study at any time.